Active Ingredient(s):Peginesatide FDA Approved: * March 27, 2012 Pharm Company: *AFFYMAX INC Category:Anemia
Peginesatide (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin.
It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis. On February 23, 2013, Affymax and Takeda issued a press release indicating that they were recalling all batches of pegi...
* May have multiple approval dates, manufacturers, or labelers.